Hoeh N

Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, 22 Park Avenue, Grafton, Auckland 1023, New Zealand. Electronic address: n.hoeh@auckland.ac.nz.

7 papers · ORCID

ArticleLSD

LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial.

Daldegan-Bueno D, Donegan CJ, Sumner R +11

Europe PMC2026
ArticleLSD

LSD microdosing in major depressive disorder: results from an open-label trial.

Daldegan-Bueno D, Donegan CJ, Sumner R +12

Europe PMC2026
ArticleLSD

Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures.

Donegan CJ, Daldegan-Bueno D, Noorani T +9

Europe PMC2025
ArticleLSD

LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

Daldegan-Bueno D, Donegan CJ, Forsyth A +16

Europe PMC2024
ArticleLSD

LSD increases sleep duration the night after microdosing.

Allen N, Jeremiah A, Murphy R +8

Europe PMC2024
ArticleLSD

An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).

Donegan CJ, Daldegan-Bueno D, Sumner R +15

Europe PMC2023
ArticleLSD

MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers.

Murphy RJ, Sumner RL, Evans W +8

Europe PMC2021